Total Payments
$8,514
2024 Payments
$1,160
Companies
58
Transactions
528
Medicare Patients
2,090
Medicare Billing
$229,205
Payment Breakdown by Category
Food & Beverage$8,364 (98.2%)
Education$150.63 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,364 | 520 | 98.2% |
| Education | $150.63 | 8 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $909.53 | 54 | $0 (2024) |
| ABBVIE INC. | $897.12 | 64 | $0 (2024) |
| Amgen Inc. | $797.55 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $744.85 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $660.23 | 42 | $0 (2024) |
| Lilly USA, LLC | $519.25 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $322.01 | 17 | $0 (2024) |
| PFIZER INC. | $315.35 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $277.36 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $276.55 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,160 | 65 | GlaxoSmithKline, LLC. ($161.25) |
| 2023 | $1,396 | 72 | AbbVie Inc. ($220.33) |
| 2022 | $1,311 | 80 | ABBVIE INC. ($196.15) |
| 2021 | $1,120 | 70 | AbbVie Inc. ($337.15) |
| 2020 | $600.27 | 38 | Allergan, Inc. ($135.65) |
| 2019 | $706.55 | 45 | Novo Nordisk Inc ($81.92) |
| 2018 | $992.74 | 65 | AstraZeneca Pharmaceuticals LP ($187.06) |
| 2017 | $1,227 | 93 | AstraZeneca Pharmaceuticals LP ($227.87) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Hematology | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: PAIN | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/12/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Oncology | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 718 | 1,875 | $184,793 | $90,462 |
| 2022 | 9 | 456 | 1,204 | $132,915 | $67,475 |
| 2021 | 10 | 490 | 741 | $90,340 | $43,776 |
| 2020 | 12 | 426 | 562 | $64,960 | $27,491 |
Total Patients
2,090
Total Services
4,382
Medicare Billing
$229,205
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 406 | $54,810 | $35,189 | 64.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 67 | 522 | $44,370 | $19,321 | 43.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 65 | 368 | $29,440 | $13,451 | 45.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 51 | 214 | $13,910 | $6,419 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 103 | $9,785 | $5,683 | 58.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 26 | $4,680 | $3,123 | 66.7% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 24 | 24 | $7,453 | $2,311 | 31.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 23 | 23 | $3,750 | $1,429 | 38.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 60 | 60 | $2,100 | $1,055 | 50.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $5,775 | $872.68 | 15.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $4,550 | $470.21 | 10.3% |
| 93050 | Analysis of central arterial pressure with review by physician | Office | 2023 | 23 | 23 | $460.00 | $275.77 | 59.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 24 | $840.00 | $247.71 | 29.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 15 | $525.00 | $228.80 | 43.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 14 | 14 | $840.00 | $200.06 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $980.00 | $153.72 | 15.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 15 | $525.00 | $33.00 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 394 | $53,190 | $34,360 | 64.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 58 | 564 | $47,940 | $23,534 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 87 | $8,265 | $4,811 | 58.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 32 | 49 | $3,920 | $1,858 | 47.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 12 | 12 | $6,300 | $1,137 | 18.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 30 | 30 | $10,500 | $1,078 | 10.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 37 | 39 | $1,365 | $527.71 | 38.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $840.00 | $131.12 | 15.6% |
About Dr. Dina White, MD
Dr. Dina White, MD is a Family Medicine healthcare provider based in Sugarland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922061548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dina White, MD has received a total of $8,514 in payments from pharmaceutical and medical device companies, with $1,160 received in 2024. These payments were reported across 528 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($8,364).
As a Medicare-enrolled provider, White has provided services to 2,090 Medicare beneficiaries, totaling 4,382 services with total Medicare billing of $229,205. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Sugarland, TX
- Active Since 04/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922061548
Products in Payments
- FARXIGA (Drug) $475.47
- VRAYLAR (Drug) $390.05
- UBRELVY (Drug) $365.99
- Ozempic (Drug) $365.29
- MOUNJARO (Drug) $334.69
- TRELEGY ELLIPTA (Drug) $326.51
- Kerendia (Drug) $322.01
- XARELTO (Drug) $276.55
- Otezla (Drug) $249.68
- QULIPTA (Drug) $233.82
- Vascepa (Drug) $212.03
- SHINGRIX (Biological) $208.59
- Aimovig (Biological) $205.09
- JARDIANCE (Drug) $201.56
- Desara (Device) $200.26
- CYCLOSET (Drug) $177.87
- NURTEC ODT (Drug) $168.37
- Rybelsus (Drug) $135.24
- Prolia (Biological) $134.50
- EVENITY (Biological) $129.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.